Immunomodulatory activity of macromolecular polysaccharide isolated from Grifola frondosa

Xiao-Lei Ma1, Meng Meng1, Li-Rong Han1

  • 1Key Laboratory of Food Nutrition and Safety, Ministry of Education, College of Food Engineering and Biotechnology, Tianjin University of Science & Technology, Tianjin 300072, China.

Insights

Grifola frondosa polysaccharide (GFP-A) enhances immune function by stimulating phagocytosis and splenocyte proliferation. This component also boosts thymus and spleen indices, cytokine production, and T lymphocyte expression, counteracting immunosuppression.

Area of Science:

  • Immunology
  • Pharmacology
  • Mycology

Background:

  • Immunosuppression is a critical condition affecting immune system function.
  • Grifola frondosa polysaccharides (GFP) are known for potential biological activities.
  • Understanding the specific immune-modulating effects of GFP components is crucial.

Purpose of the Study:

  • To evaluate the immune-modulating effects of a Grifola frondosa polysaccharide component (GFP-A).
  • To investigate GFP-A's efficacy in a cytoxan (CTX)-induced immunosuppression mouse model.
  • To determine GFP-A's impact on phagocytosis, splenocyte proliferation, and immune cell populations.

Main Methods:

  • Mouse peritoneal macrophage and CTX-induced immunosuppression models were utilized.
  • Phagocytotic and mononuclear phagocytic system function assays were performed.
  • Splenocyte proliferation assays, thymus and spleen index measurements, and analysis of cytokine mRNA and T lymphocyte expression were conducted.

Main Results:

  • GFP-A significantly stimulated phagocytosis and splenocyte proliferation, particularly when combined with ConA or LPS.
  • Administration of GFP-A increased thymus and spleen indices and altered spleen enzyme levels (LDH, ACP).
  • GFP-A elevated mRNA levels of IL-1β, IL-2, IL-6, and IFN-γ, and increased CD4(+) and CD8(+) T lymphocyte expression in splenocytes, counteracting CTX-induced suppression.

Conclusions:

  • The study demonstrates that GFP-A possesses significant immune-modulating properties.
  • GFP-A effectively enhances cellular and humoral immune responses.
  • These findings suggest GFP-A has potential as a therapeutic agent for counteracting immunosuppression.